메뉴 건너뛰기




Volumn 17, Issue 32, 2011, Pages 3560-3576

Prodrugs and endogenous transporters: Are they suitable tools for drug targeting into the central nervous system?

Author keywords

AET systems; CMT systems; Endogenous transporters; Lipidization; Prodrug; RMT systems

Indexed keywords

1,3 DIACETYL 2 KETOPROFEN GLYCERIDE; 6 BROMO ASCORBATE; 7 CHLOROKYNURENIC ACID; ACETORPHAN; ACETYL THIORPHAN; ASCORBIC ACID; ASTEMIZOLE; CODEINE; DIAMORPHINE; DICLOFENAMIC ACID; DIPHENHYDRAMINE; DOPAMINE; DOXORUBICIN; FOSCARNET; GLUCOSE; KETOPROFEN; KYNURENIC ACID; L 4 CHLOROKYNUREINE; LEVODOPA; MEPYRAMINE; MORPHINE; NIPECOTIC ACID; OXYBATE SODIUM; PROBENECID; PRODRUG; TERFENADINE; THIORPHAN; TYROSINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID;

EID: 82055206096     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211798194486     Document Type: Article
Times cited : (33)

References (156)
  • 1
    • 1642496918 scopus 로고    scopus 로고
    • Understanding and circumventing the blood-brain barrier
    • Begley DJ. Understanding and circumventing the blood-brain barrier. Acta Paediatr Suppl 2003; 443: 83-91.
    • (2003) Acta Paediatr Suppl , vol.443 , pp. 83-91
    • Begley, D.J.1
  • 2
    • 6944255523 scopus 로고    scopus 로고
    • Delivery of therapeutic agents to the central nervous system: The problems and the possibilities
    • Begley DJ. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol Ther 2004; 104: 29-45.
    • (2004) Pharmacol Ther , vol.104 , pp. 29-45
    • Begley, D.J.1
  • 4
    • 67650033008 scopus 로고    scopus 로고
    • Characteristics of compounds that cross the bloodbrain barrier
    • Banks WA. Characteristics of compounds that cross the bloodbrain barrier. BMC Neurol 2009; 9(Suppl 1): S3
    • (2009) BMC Neurol , vol.9 , Issue.SUPPL. 1
    • Banks, W.A.1
  • 5
    • 48949117580 scopus 로고    scopus 로고
    • The blood-central nervous system barriers actively control immune cell entry into the central nervous system
    • Engelhardt B. The blood-central nervous system barriers actively control immune cell entry into the central nervous system. Curr Pharm Des 2008; 14: 1555-65.
    • (2008) Curr Pharm Des , vol.14 , pp. 1555-1565
    • Engelhardt, B.1
  • 6
    • 0033756459 scopus 로고    scopus 로고
    • Transporter-Mediated Permeation of Drugs Across the Blood-Brain Barrier
    • Tamai I, Tsuji A. Transporter-Mediated Permeation of Drugs Across the Blood-Brain Barrier. J Pharm Sci 2000; 89: 1371-88.
    • (2000) J Pharm Sci , vol.89 , pp. 1371-1388
    • Tamai, I.1    Tsuji, A.2
  • 7
    • 67651100897 scopus 로고    scopus 로고
    • Closing the gap between the in-vivo and in-vitro blood-brain barrier tightness
    • Cohen-Kashi Malina K, Cooper I, Teichberg VI. Closing the gap between the in-vivo and in-vitro blood-brain barrier tightness. Brain Res 2009; 1284: 12-21.
    • (2009) Brain Res , vol.1284 , pp. 12-21
    • Cohen-Kashi Malina, K.1    Cooper, I.2    Teichberg, V.I.3
  • 8
    • 0019124032 scopus 로고
    • Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability
    • Levin V A. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem 1980; 23: 682-4.
    • (1980) J Med Chem , vol.23 , pp. 682-684
    • Levin, V.A.1
  • 9
    • 44849099528 scopus 로고    scopus 로고
    • Blood-neural barrier: Its diversity and coordinated cell-to-cell communication
    • Choi YK, Kim KW. Blood-neural barrier: its diversity and coordinated cell-to-cell communication. BMB reports 2008; 41: 345-52.
    • (2008) BMB Reports , vol.41 , pp. 345-352
    • Choi, Y.K.1    Kim, K.W.2
  • 10
    • 23644440809 scopus 로고    scopus 로고
    • Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route
    • Johanson CE, Duncan JA, Stopa EG, Baird A. Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route. Pharm Res 2005; 22: 1011-37.
    • (2005) Pharm Res , vol.22 , pp. 1011-1037
    • Johanson, C.E.1    Duncan, J.A.2    Stopa, E.G.3    Baird, A.4
  • 11
    • 0027976519 scopus 로고
    • Localisation of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs
    • Ghersi-Egea J, Leninger-Muller B, Suleman G, Siest G, Minn A. Localisation of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs. J Neurochem 1994; 62: 1089-96
    • (1994) J Neurochem , vol.62 , pp. 1089-1196
    • Ghersi-Egea, J.1    Leninger-Muller, B.2    Suleman, G.3    Siest, G.4    Minn, A.5
  • 12
    • 0018907903 scopus 로고
    • Barrier mechanisms for neutrotransmitter monoamines in the choroid plexus
    • Lindvall M, Hardebo J, Owman C. Barrier mechanisms for neutrotransmitter monoamines in the choroid plexus. Acta Physiol Scand 1980; 108: 215-21.
    • (1980) Acta Physiol Scand , vol.108 , pp. 215-221
    • Lindvall, M.1    Hardebo, J.2    Owman, C.3
  • 13
    • 33747162901 scopus 로고    scopus 로고
    • Brain protection at the blood-cerebrospinal fluid interface involves a glutathione- dependent metabolic barrier mechanism
    • Ghersi-Egea J, Strazielle N, Murat A, Jouvet A, Buénerd A, Belin M. Brain protection at the blood-cerebrospinal fluid interface involves a glutathione- dependent metabolic barrier mechanism. J Cereb Blood Flow Metab 2006; 26: 1165-75.
    • (2006) J Cereb Blood Flow Metab , vol.26 , pp. 1165-1175
    • Ghersi-Egea, J.1    Strazielle, N.2    Murat, A.3    Jouvet, A.4    Buénerd, A.5    Belin, M.6
  • 14
    • 44349163325 scopus 로고    scopus 로고
    • Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier
    • Bauer B, Hartz A, Lucking J, Yang X, Pollack G, Miller D. Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier. J Cereb Blood Flow Metab 2008; 28: 1222-34.
    • (2008) J Cereb Blood Flow Metab , vol.28 , pp. 1222-1234
    • Bauer, B.1    Hartz, A.2    Lucking, J.3    Yang, X.4    Pollack, G.5    Miller, D.6
  • 15
  • 18
    • 12344273726 scopus 로고    scopus 로고
    • The Blood-Brain Barrier: Bottleneck in Brain Drug Development
    • Pardridge W M. The Blood-Brain Barrier: Bottleneck in Brain Drug Development. NeuroRx 2005; 2: 3-14.
    • (2005) NeuroRx , vol.2 , pp. 3-14
    • Pardridge, W.M.1
  • 19
    • 33845784758 scopus 로고    scopus 로고
    • Blood-brain barrier delivery
    • Pardridge W M. Blood-brain barrier delivery. Drug Discov Today 2007; 12: 54-61.
    • (2007) Drug Discov Today , vol.12 , pp. 54-61
    • Pardridge, W.M.1
  • 21
    • 0842346110 scopus 로고    scopus 로고
    • Development of an in vitro blood-brain barrier model-cytotoxicity of mercury and aluminium
    • Toimela T, Maenpaa H, Mannerstrom M, Tahti H. Development of an in vitro blood-brain barrier model-cytotoxicity of mercury and aluminium. Toxicol Appl Pharmacol 2004; 195: 73-82.
    • (2004) Toxicol Appl Pharmacol , vol.195 , pp. 73-82
    • Toimela, T.1    Maenpaa, H.2    Mannerstrom, M.3    Tahti, H.4
  • 22
    • 20044368980 scopus 로고    scopus 로고
    • Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapurtic effects of potentially central active drugs
    • Dalpiaz A, Pavan B, Vertuani S, et al. Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapurtic effects of potentially central active drugs. Eur J Pharm Sci 2005; 24: 259-69.
    • (2005) Eur J Pharm Sci , vol.24 , pp. 259-269
    • Dalpiaz, A.1    Pavan, B.2    Vertuani, S.3
  • 23
    • 34047252695 scopus 로고    scopus 로고
    • Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate
    • Dalpiaz A, Filosa R, de Caprariis P, et al. Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate. Int J Pharm 2007; 336: 133-9.
    • (2007) Int J Pharm , vol.336 , pp. 133-139
    • Dalpiaz, A.1    Filosa, R.2    de Caprariis, P.3
  • 24
    • 21344451667 scopus 로고    scopus 로고
    • Colloidal carriers and blood-brain barrier (BBB) translocation: A way to deliver drugs to the brain?
    • Garcia-Garcia E, Andrieux K, Gil S, Couvreur P. Colloidal carriers and blood-brain barrier (BBB) translocation: A way to deliver drugs to the brain? Int J Pharmaceut 2005; 298: 274-92.
    • (2005) Int J Pharmaceut , vol.298 , pp. 274-292
    • Garcia-Garcia, E.1    Andrieux, K.2    Gil, S.3    Couvreur, P.4
  • 25
    • 0141508829 scopus 로고    scopus 로고
    • Modifying peptide properties by prodrug design for enhanced transport into the CNS
    • Prokai-Tatrai K, Prokai L. Modifying peptide properties by prodrug design for enhanced transport into the CNS. Prog Drug Res 2003; 61: 155-88.
    • (2003) Prog Drug Res , vol.61 , pp. 155-188
    • Prokai-Tatrai, K.1    Prokai, L.2
  • 26
    • 0031695039 scopus 로고    scopus 로고
    • Blood-brain barrier permeation: Molecular parameters governing passive diffusion
    • Fischer H, Gottschlich R, Seelig A. Blood-brain barrier permeation: molecular parameters governing passive diffusion. J Membr Biol 1998; 165: 201-11.
    • (1998) J Membr Biol , vol.165 , pp. 201-211
    • Fischer, H.1    Gottschlich, R.2    Seelig, A.3
  • 27
    • 51249188620 scopus 로고
    • The movement of molecules across lipid membranes: A molecular theory
    • Trauble H. The movement of molecules across lipid membranes: a molecular theory. J Membr Biol 1971; 4: 193-208.
    • (1971) J Membr Biol , vol.4 , pp. 193-208
    • Trauble, H.1
  • 28
    • 0029782010 scopus 로고    scopus 로고
    • Proton transport across transient single-file water pores in a lipid membrane studied by molecular dynamics simulations
    • Marrink SJ, Jahnig F, Berendsen HJC. Proton transport across transient single-file water pores in a lipid membrane studied by molecular dynamics simulations. Biophys J 1996; 71: 632-47.
    • (1996) Biophys J , vol.71 , pp. 632-647
    • Marrink, S.J.1    Jahnig, F.2    Berendsen, H.J.C.3
  • 29
    • 51249188620 scopus 로고
    • The movement of molecules across lipid membranes: A molecular theory
    • Trauble H. The movement of molecules across lipid membranes: a molecular theory. J Membr Biol 1971; 4: 193-208.
    • (1971) J Membr Biol , vol.4 , pp. 193-208
    • Trauble, H.1
  • 30
    • 0029782010 scopus 로고    scopus 로고
    • Proton transport across transient single-file water pores in a lipid membrane studied by molecular dynamics simulations
    • Marrink SJ, Jahnig F, Berendsen HJC. Proton transport across transient single-file water pores in a lipid membrane studied by molecular dynamics simulations. Biophys J 1996; 71: 632-47.
    • (1996) Biophys J , vol.71 , pp. 632-647
    • Marrink, S.J.1    Jahnig, F.2    Berendsen, H.J.C.3
  • 31
    • 0014682986 scopus 로고
    • Molecular forces governing nonelectrolyte permeation through cell membranes
    • Diamond JM, Wright EM. Molecular forces governing nonelectrolyte permeation through cell membranes. Proc R Soc Lond B Biol Sci 1969; 171: 273-16.
    • (1969) Proc R Soc Lond B Biol Sci , vol.171 , pp. 273-316
    • Diamond, J.M.1    Wright, E.M.2
  • 32
    • 0025064041 scopus 로고
    • Pharmacokinetics of chlorambuciltertiary butyl ester, a lipophilic chrambucil derivative that achieves and maintains high concentrations in brain
    • Greig NH, Daly EM, Sweeney DJ, Rapoport SI. Pharmacokinetics of chlorambuciltertiary butyl ester, a lipophilic chrambucil derivative that achieves and maintains high concentrations in brain. Cancer Chemother Pharmacol 1990; 25: 320-5.
    • (1990) Cancer Chemother Pharmacol , vol.25 , pp. 320-325
    • Greig, N.H.1    Daly, E.M.2    Sweeney, D.J.3    Rapoport, S.I.4
  • 33
    • 0014888279 scopus 로고
    • Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard
    • Oldendorf WH. Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard. Brain Res 1970; 24: 372-6.
    • (1970) Brain Res , vol.24 , pp. 372-376
    • Oldendorf, W.H.1
  • 34
    • 0015484902 scopus 로고
    • Blood-brain barrier penetration of morphine, codeine, heroin, and methadone after carotid injection
    • Oldendorf WH, Human S, Braun L, Oldendorf SZ. Blood-brain barrier penetration of morphine, codeine, heroin, and methadone after carotid injection. Science 1972; 178: 984-6.
    • (1972) Science , vol.178 , pp. 984-986
    • Oldendorf, W.H.1    Human, S.2    Braun, L.3    Oldendorf, S.Z.4
  • 36
    • 0026659612 scopus 로고
    • "Mixed inhibitorprodrug" as a new approach toward systemically active inhibitors of enkephalin-degrading enzymes
    • Fournie-Zaluski MC, Coric P, Turcaud S, et al. "Mixed inhibitorprodrug" as a new approach toward systemically active inhibitors of enkephalin-degrading enzymes. J Med Chem 1992; 35: 2473-81.
    • (1992) J Med Chem , vol.35 , pp. 2473-2481
    • Fournie-Zaluski, M.C.1    Coric, P.2    Turcaud, S.3
  • 37
    • 0022500375 scopus 로고
    • Pharmacological properties of acetorphan, a parentererally active "enkephalinase" inhibitor
    • Lecomte JM, Costentin J, Vlaiculescu A, et al. Pharmacological properties of acetorphan, a parentererally active "enkephalinase" inhibitor. J Pharmacol Exp Ther 1986; 237: 937-44.
    • (1986) J Pharmacol Exp Ther , vol.237 , pp. 937-944
    • Lecomte, J.M.1    Costentin, J.2    Vlaiculescu, A.3
  • 38
    • 0027525658 scopus 로고
    • Analgesic potency of S-acethylthiorphan after intravenous administration to mice
    • Lambert SM, Mergen F, Poupaert JH, Dumont P. Analgesic potency of S-acethylthiorphan after intravenous administration to mice. Eur J Pharmacol 1993; 243: 129-34.
    • (1993) Eur J Pharmacol , vol.243 , pp. 129-134
    • Lambert, S.M.1    Mergen, F.2    Poupaert, J.H.3    Dumont, P.4
  • 39
    • 0028153458 scopus 로고
    • Synthesis and evaluation of a redox chemical delivery system for brain-enhanced dopamine containing an activated carbamate-type ester
    • Omar FA, Farag H, Bodor N. Synthesis and evaluation of a redox chemical delivery system for brain-enhanced dopamine containing an activated carbamate-type ester. J Drug Target 1994; 2: 309-16.
    • (1994) J Drug Target , vol.2 , pp. 309-316
    • Omar, F.A.1    Farag, H.2    Bodor, N.3
  • 40
    • 0030560989 scopus 로고    scopus 로고
    • New systems for the specific delivery and sustained release of dopamine to the brain
    • Carelli V, Liberatore F, Scipione L, et al. New systems for the specific delivery and sustained release of dopamine to the brain. J Control Rel 1996, 42: 209-16.
    • (1996) J Control Rel , vol.42 , pp. 209-216
    • Carelli, V.1    Liberatore, F.2    Scipione, L.3
  • 41
    • 0034453632 scopus 로고    scopus 로고
    • Improved brain delivery of a nonsteroidal anti-inflammatory drug with a synthetic glyceride ester: A preliminary attempt at a CNS drug delivery system for therapy of Alzheimer's disease
    • Yoshiharu D, Hideki H, Shinobu F, et al. Improved brain delivery of a nonsteroidal anti-inflammatory drug with a synthetic glyceride ester: a preliminary attempt at a CNS drug delivery system for therapy of Alzheimer's disease. J. Drug Target 2000; 8: 371-81.
    • (2000) J. Drug Target , vol.8 , pp. 371-381
    • Yoshiharu, D.1    Hideki, H.2    Shinobu, F.3
  • 42
    • 0036788234 scopus 로고    scopus 로고
    • Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: Its involvement in neurotransmitter metabolite clearance from the brain
    • Ohtsuki S, Asaba H, Takanaga H, et al. Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain. J Neurochem 2002; 83: 57-66.
    • (2002) J Neurochem , vol.83 , pp. 57-66
    • Ohtsuki, S.1    Asaba, H.2    Takanaga, H.3
  • 43
    • 77952354904 scopus 로고    scopus 로고
    • Involvement of multidrug resistance-associated protein 4 in efflux transport of prostaglandin E(2) across mouse blood-brain barrier and its inhibition by intravenous administration of cephalosporins
    • Akanuma S, Hosoya K, Ito S, Tachikawa M, Terasaki T, Ohtsuki S. Involvement of multidrug resistance-associated protein 4 in efflux transport of prostaglandin E(2) across mouse blood-brain barrier and its inhibition by intravenous administration of cephalosporins. J Pharmacol Exp Ther 2010; 333: 912-9.
    • (2010) J Pharmacol Exp Ther , vol.333 , pp. 912-919
    • Akanuma, S.1    Hosoya, K.2    Ito, S.3    Tachikawa, M.4    Terasaki, T.5    Ohtsuki, S.6
  • 45
    • 34547637590 scopus 로고    scopus 로고
    • Drug Targeting to the Brain
    • Pardridge WM. Drug Targeting to the Brain. Pharm Res 2007; 24: 1733-44.
    • (2007) Pharm Res , vol.24 , pp. 1733-1744
    • Pardridge, W.M.1
  • 48
    • 0015186836 scopus 로고
    • Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection
    • Oldendorf W H. Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol 1971; 221: 1629-39
    • (1971) Am J Physiol , vol.221 , pp. 1629-1639
    • Oldendorf, W.H.1
  • 49
    • 0021020420 scopus 로고
    • Brain metabolism: A perspective from the bloodbrain barrier
    • Pardridge WM. Brain metabolism: a perspective from the bloodbrain barrier. Physiol Rev 1983; 63: 1481-535.
    • (1983) Physiol Rev , vol.63 , pp. 1481-1535
    • Pardridge, W.M.1
  • 50
    • 0034194081 scopus 로고    scopus 로고
    • Ascorbate regulation and its neuroprotective role in the brain
    • Rice ME Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci 2000; 23: 209-16.
    • (2000) Trends Neurosci , vol.23 , pp. 209-216
    • Rice, M.E.1
  • 51
    • 0032508585 scopus 로고    scopus 로고
    • Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98)
    • Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 1998; 273: 23629-32.
    • (1998) J Biol Chem , vol.273 , pp. 23629-23632
    • Kanai, Y.1    Segawa, H.2    Miyamoto, K.3    Uchino, H.4    Takeda, E.5    Endou, H.6
  • 53
    • 0036208155 scopus 로고    scopus 로고
    • Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): Insights into the mechanisms of substrate recognition
    • Uchino H, Kanai Y, Kim D, et al. Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. Mol Pharmacol 2002; 61: 729-37.
    • (2002) Mol Pharmacol , vol.61 , pp. 729-737
    • Uchino, H.1    Kanai, Y.2    Kim, D.3
  • 54
    • 0037291723 scopus 로고    scopus 로고
    • System L: Heteromeric exchangers of large, neutral amino acids involved in directional tranport
    • Verrey F. System L: heteromeric exchangers of large, neutral amino acids involved in directional tranport. Pflugers Arch 2003; 445: 529-33.
    • (2003) Pflugers Arch , vol.445 , pp. 529-533
    • Verrey, F.1
  • 55
    • 12344273724 scopus 로고    scopus 로고
    • Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems
    • Tsuji A. Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems. NeuroRx 2005; 2: 54-62.
    • (2005) NeuroRx , vol.2 , pp. 54-62
    • Tsuji, A.1
  • 56
    • 0025123704 scopus 로고
    • Brain-type glucose transporter (GLUT 1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridisation
    • Pardridge WM, Boado R.J, Farrell CR. Brain-type glucose transporter (GLUT 1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridisation. J Biol Chem 1990; 265: 18035-40.
    • (1990) J Biol Chem , vol.265 , pp. 18035-18040
    • Pardridge, W.M.1    Boado, R.J.2    Farrell, C.R.3
  • 57
    • 0016671063 scopus 로고
    • Kinetics of blood-brain barrier transport of hexoses
    • Pardridge WM, Olendorf WH. Kinetics of blood-brain barrier transport of hexoses. Biochim Biophys Acta 1975; 382: 377-92.
    • (1975) Biochim Biophys Acta , vol.382 , pp. 377-392
    • Pardridge, W.M.1    Olendorf, W.H.2
  • 58
    • 45549092587 scopus 로고    scopus 로고
    • Transmembrane segment 6 of the Glut1 glucose transporter is an outer helix and contains amino acid side chains essential for transport activity
    • Mueckler M, Makepeace C. Transmembrane segment 6 of the Glut1 glucose transporter is an outer helix and contains amino acid side chains essential for transport activity. J Biol Chem 2008; 283: 11550-5.
    • (2008) J Biol Chem , vol.283 , pp. 11550-11555
    • Mueckler, M.1    Makepeace, C.2
  • 59
    • 66249128230 scopus 로고    scopus 로고
    • Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats
    • Gynther M, Ropponen J, Laine K, et al. Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats. J Med Chem 2009; 52: 3348-53.
    • (2009) J Med Chem , vol.52 , pp. 3348-3353
    • Gynther, M.1    Ropponen, J.2    Laine, K.3
  • 60
    • 0007844316 scopus 로고    scopus 로고
    • Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs
    • Griffiths M, Beaumont N, Yao SY, et al. Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nat Med 1997; 3: 25-6.
    • (1997) Nat Med , vol.3 , pp. 25-26
    • Griffiths, M.1    Beaumont, N.2    Yao, S.Y.3
  • 61
    • 0031439882 scopus 로고    scopus 로고
    • Molecular cloning and characterization of a nitrobenzylthioinosineinsensitive (ei) equilibrative nucleoside transporter from human placenta
    • Griffiths M, Yao SY, Abidi F, et al. Molecular cloning and characterization of a nitrobenzylthioinosineinsensitive (ei) equilibrative nucleoside transporter from human placenta. Biochem J 1997; 328: 739-43.
    • (1997) Biochem J , vol.328 , pp. 739-743
    • Griffiths, M.1    Yao, S.Y.2    Abidi, F.3
  • 62
    • 0032467105 scopus 로고    scopus 로고
    • Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Naƥ/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine
    • Ritzel MW, Yao SY, Ng AM, Mackey JR, Cass CE, Young JD. Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Naƥ/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine. Mol Membr Biol 1998; 15: 203-11.
    • (1998) Mol Membr Biol , vol.15 , pp. 203-211
    • Ritzel, M.W.1    Yao, S.Y.2    Ng, A.M.3    Mackey, J.R.4    Cass, C.E.5    Young, J.D.6
  • 63
    • 0030938889 scopus 로고    scopus 로고
    • Molecular cloning and functional expression of cDNAs encoding a human Na??nucleoside cotransporter (hCNT1)
    • Ritzel MW, Yao SY, Huang MY, Elliott JF, Cass CE, Young JD. Molecular cloning and functional expression of cDNAs encoding a human Na??nucleoside cotransporter (hCNT1). Am J Physiol 1997; 272: C707-C14.
    • (1997) Am J Physiol , vol.272
    • Ritzel, M.W.1    Yao, S.Y.2    Huang, M.Y.3    Elliott, J.F.4    Cass, C.E.5    Young, J.D.6
  • 64
    • 0035951808 scopus 로고    scopus 로고
    • Molecular identification and characterization of novel human and mouse concentrative Naƥ- nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides
    • Ritzel MW, Ng AM, Yao SY, et al. Molecular identification and characterization of novel human and mouse concentrative Naƥ- nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides. J Biol Chem 2001; 276: 2914-27.
    • (2001) J Biol Chem , vol.276 , pp. 2914-2927
    • Ritzel, M.W.1    Ng, A.M.2    Yao, S.Y.3
  • 65
    • 18144403118 scopus 로고    scopus 로고
    • Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes
    • Baldwin SA, Yao SY, Hyde RJ, et al. Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J Biol Chem 2005; 280: 15880-7.
    • (2005) J Biol Chem , vol.280 , pp. 15880-15887
    • Baldwin, S.A.1    Yao, S.Y.2    Hyde, R.J.3
  • 67
    • 0016836221 scopus 로고
    • Independent blood-brain barrier transport systems for nucleic acid precursors
    • Cornford EM, Oldendorf WH. Independent blood-brain barrier transport systems for nucleic acid precursors. Biochim Biophys Acta 1975; 394: 211-9.
    • (1975) Biochim Biophys Acta , vol.394 , pp. 211-219
    • Cornford, E.M.1    Oldendorf, W.H.2
  • 68
    • 0028012869 scopus 로고
    • Blood-brain barrier transport and brain metabolism of adenosine and adenosine analogs
    • Pardridge W M, Yoshikawa T, Kang YS, Miller LP. Blood-brain barrier transport and brain metabolism of adenosine and adenosine analogs. J Pharmacol Exp Ther 1994; 268: 14-8.
    • (1994) J Pharmacol Exp Ther , vol.268 , pp. 14-18
    • Pardridge, W.M.1    Yoshikawa, T.2    Kang, Y.S.3    Miller, L.P.4
  • 69
    • 4644360379 scopus 로고    scopus 로고
    • Interaction of nucleoside analogues with nucleoside transporters in rat brain endothelial cells
    • Chishty M, Begley D J, Abbott N J, Reichel A. Interaction of nucleoside analogues with nucleoside transporters in rat brain endothelial cells. J Drug Targ 2004; 12: 265-72.
    • (2004) J Drug Targ , vol.12 , pp. 265-272
    • Chishty, M.1    Begley, D.J.2    Abbott, N.J.3    Reichel, A.4
  • 70
    • 0030837750 scopus 로고    scopus 로고
    • Expression of monocarboxylate transporter MCT1 by brain endothelium and glia in adult and suckling rats
    • Gerhart DZ, Enerson BE, Zhdankina OY, Leino RL, Drewes LR. Expression of monocarboxylate transporter MCT1 by brain endothelium and glia in adult and suckling rats. Am J Physiol 1997; 273: E207-13.
    • (1997) Am J Physiol , vol.273
    • Gerhart, D.Z.1    Enerson, B.E.2    Zhdankina, O.Y.3    Leino, R.L.4    Drewes, L.R.5
  • 71
    • 70350223814 scopus 로고    scopus 로고
    • Blood-brain barrier transporters and response to CNS-active drugs
    • Urquhart BL, Kim RB. Blood-brain barrier transporters and response to CNS-active drugs. Eur J Clin Pharmacol 2009; 65: 1063-70.
    • (2009) Eur J Clin Pharmacol , vol.65 , pp. 1063-1070
    • Urquhart, B.L.1    Kim, R.B.2
  • 72
    • 4644337779 scopus 로고    scopus 로고
    • GHB (gamma-hydroxybutyrate) carriermediated transport across the blood-brain barrier
    • Bhattacharya I, Boje KM. GHB (gamma-hydroxybutyrate) carriermediated transport across the blood-brain barrier. J Pharmacol Exp Ther 2004; 311: 92-8.
    • (2004) J Pharmacol Exp Ther , vol.311 , pp. 92-98
    • Bhattacharya, I.1    Boje, K.M.2
  • 73
    • 0032735306 scopus 로고    scopus 로고
    • Immunohistochemical and functional characterization of pH-dependent intestinal absorption of organic weak acids by monocarboxylic acid transporter MCT1
    • Tamai I, Sai Y, Ono A, et al. Immunohistochemical and functional characterization of pH-dependent intestinal absorption of organic weak acids by monocarboxylic acid transporter MCT1. J Pharm Pharmacol 1999; 51: 1113-21.
    • (1999) J Pharm Pharmacol , vol.51 , pp. 1113-1121
    • Tamai, I.1    Sai, Y.2    Ono, A.3
  • 75
    • 0032705918 scopus 로고    scopus 로고
    • Cloning and functional characterization of the human sodium-dependent Vitamin C transporters hSVCT1 and hSVCT2
    • Durawala R, Song J, Koh W.S, Rumsey SC, Levine M. Cloning and functional characterization of the human sodium-dependent Vitamin C transporters hSVCT1 and hSVCT2. FEBS Lett 1999; 460: 480-4.
    • (1999) FEBS Lett , vol.460 , pp. 480-484
    • Durawala, R.1    Song, J.2    Koh, W.S.3    Rumsey, S.C.4    Levine, M.5
  • 76
    • 0033533578 scopus 로고    scopus 로고
    • Human placental sodiumdependent vitamin C transporter (SVCT2): Molecular cloning andtransport function
    • Rajan DP, Huang W, Dutta B, et al. Human placental sodiumdependent vitamin C transporter (SVCT2): molecular cloning andtransport function. Biochem Biophis Res Comm 1999; 262: 762-8.
    • (1999) Biochem Biophis Res Comm , vol.262 , pp. 762-768
    • Rajan, D.P.1    Huang, W.2    Dutta, B.3
  • 77
    • 85047699109 scopus 로고    scopus 로고
    • Acorbic acid transporter Slc23a1 is essential for Vitamin C transport into the brain and forperinatal survival
    • Sotiriou S, Gispert S, Cheng J, et al. Acorbic acid transporter Slc23a1 is essential for Vitamin C transport into the brain and forperinatal survival. Nature Med 2002; 8, 514-7.
    • (2002) Nature Med , vol.8 , pp. 514-517
    • Sotiriou, S.1    Gispert, S.2    Cheng, J.3
  • 78
    • 0032961750 scopus 로고    scopus 로고
    • Anti-sushine Vitamin A
    • Gilchrest B. Anti-sushine Vitamin A. Nature Med 1999; 5: 376-7.
    • (1999) Nature Med , vol.5 , pp. 376-377
    • Gilchrest, B.1
  • 80
    • 0034194081 scopus 로고    scopus 로고
    • Ascorbate regulation and its neuroprotective role in the brain
    • Rice M.E. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci 2000; 23: 209-16.
    • (2000) Trends Neurosci , vol.23 , pp. 209-216
    • Rice, M.E.1
  • 81
    • 0142074875 scopus 로고    scopus 로고
    • Functional characterisation of the active ascorbic acid transport into cerebrospinal fluid using primary cultured choroids plexus cells
    • Angelow S, Haselbach M, Galla HJ. Functional characterisation of the active ascorbic acid transport into cerebrospinal fluid using primary cultured choroids plexus cells. Brain Res 2003; 988: 105-13.
    • (2003) Brain Res , vol.988 , pp. 105-113
    • Angelow, S.1    Haselbach, M.2    Galla, H.J.3
  • 82
    • 0032496763 scopus 로고    scopus 로고
    • Active transport properties of porcine choroid plexus cells in culture
    • Hakvoort A, Haselbach M, Galla H J. Active transport properties of porcine choroid plexus cells in culture. Brain Res 1998; 795: 247-56.
    • (1998) Brain Res , vol.795 , pp. 247-256
    • Hakvoort, A.1    Haselbach, M.2    Galla, H.J.3
  • 83
    • 0028228342 scopus 로고
    • Cloning and chromosomal mapping of the human non functional gene for L-gulono-γ-lactone oxidase, the enzyme for L-ascorbic acid biosynthesis missing in man
    • Nishikimi M, Fukuyama R, Minoshima S, Shimizu M, Yaghi K. Cloning and chromosomal mapping of the human non functional gene for L-gulono-γ-lactone oxidase, the enzyme for L-ascorbic acid biosynthesis missing in man. J Biol Chem 1994; 269: 23215-22.
    • (1994) J Biol Chem , vol.269 , pp. 23215-23222
    • Nishikimi, M.1    Fukuyama, R.2    Minoshima, S.3    Shimizu, M.4    Yaghi, K.5
  • 84
    • 0025913553 scopus 로고
    • Ocular ascorbate transport and metabolism
    • Rose RC, Bode AM. Ocular ascorbate transport and metabolism. Comp Biochem Physiol 1991; 100: 273-85.
    • (1991) Comp Biochem Physiol , vol.100 , pp. 273-285
    • Rose, R.C.1    Bode, A.M.2
  • 85
    • 0037203976 scopus 로고    scopus 로고
    • Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity
    • Manfredini S, Pavan, B, Vertuani S, et al. Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity. J Med Chem 2002; 45: 559-62.
    • (2002) J Med Chem , vol.45 , pp. 559-562
    • Manfredini, S.1    Pavan, B.2    Vertuani, S.3
  • 86
    • 0035016154 scopus 로고    scopus 로고
    • New therapies for Parkinson's disease
    • Djaletti R, Melamed E. New therapies for Parkinson's disease. J Neurol 2001; 248: 357-62.
    • (2001) J Neurol , vol.248 , pp. 357-362
    • Djaletti, R.1    Melamed, E.2
  • 87
    • 0027988561 scopus 로고
    • The glycine site on the NMDA receptor: Structure-activity relationships and therapeutic potential
    • Leeson PD, Iversen LL. The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential. J Med Chem 1994; 37: 4053-67.
    • (1994) J Med Chem , vol.37 , pp. 4053-4067
    • Leeson, P.D.1    Iversen, L.L.2
  • 88
    • 0030895630 scopus 로고    scopus 로고
    • Facilitated brain uptake of 4-chlorokynureine and conversion to 7-chlorokynurenic acid
    • Hokari M, Wu HQ, Schwarcz R, Smith QR. Facilitated brain uptake of 4-chlorokynureine and conversion to 7-chlorokynurenic acid. Neuropharmacol Neurotoxicol 1996; 8: 15-8.
    • (1996) Neuropharmacol Neurotoxicol , vol.8 , pp. 15-18
    • Hokari, M.1    Wu, H.Q.2    Schwarcz, R.3    Smith, Q.R.4
  • 89
    • 0016837251 scopus 로고
    • Inhibition of GABA uptake in rat brain slices by nipecotic acid, various isoxazoles and related compounds
    • Krogsgaard-Larsen P, Johnston GAR. Inhibition of GABA uptake in rat brain slices by nipecotic acid, various isoxazoles and related compounds. J Neurochem 1975; 25, 797-802.
    • (1975) J Neurochem , vol.25 , pp. 797-802
    • Krogsgaard-Larsen, P.1    Johnston, G.A.R.2
  • 90
    • 0018564097 scopus 로고    scopus 로고
    • Convulsant and anticonvulsant actions in DBA/2 mice of compounds blocking the reuptake of GABA
    • Horton RW, Collins JF, Anlezark GM, Melbrum BS. Convulsant and anticonvulsant actions in DBA/2 mice of compounds blocking the reuptake of GABA. Eur J Pharmacol 1979; 59: 75-83.
    • Eur J Pharmacol 1979 , vol.59 , pp. 75-83
    • Horton, R.W.1    Collins, J.F.2    Anlezark, G.M.3    Melbrum, B.S.4
  • 91
    • 0032897670 scopus 로고    scopus 로고
    • Synthesis, stability and pharmacological evaluation of nipecotic acid prodrugs
    • Bonina FP, Arenare L, Palagiano F, et al. Synthesis, stability and pharmacological evaluation of nipecotic acid prodrugs. J Pharm Sci 1999; 88: 561-7.
    • (1999) J Pharm Sci , vol.88 , pp. 561-567
    • Bonina, F.P.1    Arenare, L.2    Palagiano, F.3
  • 92
    • 0024555551 scopus 로고
    • Antiviral effects of phsphonoformate (PFA, foscarnet sodium)
    • Oberg B. Antiviral effects of phsphonoformate (PFA, foscarnet sodium). Pharmacol Ther 1989; 40: 213-85.
    • (1989) Pharmacol Ther , vol.40 , pp. 213-285
    • Oberg, B.1
  • 93
    • 0028299081 scopus 로고
    • Drug delivery via active transport at the bloodbrain barrier: Affinity of a prodrug of phosphonoformate for the large aminoacid transporter
    • Walker I, Nicholls D, Irwin WJ, Freeman S. Drug delivery via active transport at the bloodbrain barrier: affinity of a prodrug of phosphonoformate for the large aminoacid transporter. Int J Pharm 1994; 104: 157-67.
    • (1994) Int J Pharm , vol.104 , pp. 157-167
    • Walker, I.1    Nicholls, D.2    Irwin, W.J.3    Freeman, S.4
  • 94
    • 39749166269 scopus 로고    scopus 로고
    • Large neutral amino acid transporter enables brain drug delivery via prodrugs
    • Gynther M, Laine K, Ropponen J, et al. Large neutral amino acid transporter enables brain drug delivery via prodrugs. J Med Chem 2008; 51: 932-6.
    • (2008) J Med Chem , vol.51 , pp. 932-936
    • Gynther, M.1    Laine, K.2    Ropponen, J.3
  • 95
    • 0034729726 scopus 로고    scopus 로고
    • Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability
    • Bilsky E, Egleton RD, Mitchell SA, et al. Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability. J Med Chem 2000; 43: 2586-90.
    • (2000) J Med Chem , vol.43 , pp. 2586-2590
    • Bilsky, E.1    Egleton, R.D.2    Mitchell, S.A.3
  • 97
    • 4644258417 scopus 로고    scopus 로고
    • Antinociceptive structure-activity studies with enkephalin based oppioid glycopeptides
    • Elmagbari NO, Egleton RD, Palian MM, et al. Antinociceptive structure-activity studies with enkephalin based oppioid glycopeptides. J Pharmacol Exp Ther 2004; 311: 290-7.
    • (2004) J Pharmacol Exp Ther , vol.311 , pp. 290-297
    • Elmagbari, N.O.1    Egleton, R.D.2    Palian, M.M.3
  • 98
    • 0034737759 scopus 로고    scopus 로고
    • Systematically administered D-glucose conjugates of 7-chlorokynurenic acid are centrally available and exert anticonvulsant activity in rodents
    • Battaglia G, La Russa M, Bruno V, et al. Systematically administered D-glucose conjugates of 7-chlorokynurenic acid are centrally available and exert anticonvulsant activity in rodents. Brain Res. 2000; 860: 149-56.
    • (2000) Brain Res , vol.860 , pp. 149-156
    • Battaglia, G.1    la Russa, M.2    Bruno, V.3
  • 99
    • 0034691811 scopus 로고    scopus 로고
    • Synthesis, pharmacokinetics and anticonvulsant activity of 7-chlorokynurenic acid prodrugs
    • Bonina F, Arenare L, Ippolito R, et al. Synthesis, pharmacokinetics and anticonvulsant activity of 7-chlorokynurenic acid prodrugs. Int J Pharm 2000; 202: 79-88.
    • (2000) Int J Pharm , vol.202 , pp. 79-88
    • Bonina, F.1    Arenare, L.2    Ippolito, R.3
  • 100
    • 0022469550 scopus 로고
    • Blood-brain transfer of glucose and glucose analogues in newborn rats
    • Fuglang M, Lomholt M, Gjedde A. Blood-brain transfer of glucose and glucose analogues in newborn rats. J Neurochem 1986; 46: 1417-28.
    • (1986) J Neurochem , vol.46 , pp. 1417-1428
    • Fuglang, M.1    Lomholt, M.2    Gjedde, A.3
  • 101
    • 66249128230 scopus 로고    scopus 로고
    • Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats
    • Gynther M, Ropponen J, Laine K, et al. Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats. J Med Chem 2009; 52: 3348-53.
    • (2009) J Med Chem , vol.52 , pp. 3348-3353
    • Gynther, M.1    Ropponen, J.2    Laine, K.3
  • 102
    • 0033796167 scopus 로고    scopus 로고
    • Rationale and applications of lipids as prodrug carriers
    • Lambert DM. Rationale and applications of lipids as prodrug carriers. Eur J Pharm Sci 2000; 2: S15-27.
    • (2000) Eur J Pharm Sci , vol.2 , pp. 15-27
    • Lambert, D.M.1
  • 103
    • 0031735405 scopus 로고    scopus 로고
    • Metabolic control of kynurenic acid formation in the rat brain
    • Hodgkins PS, Schwarcz R. Metabolic control of kynurenic acid formation in the rat brain. Dev Neurosci 1998; 20: 408-16.
    • (1998) Dev Neurosci , vol.20 , pp. 408-416
    • Hodgkins, P.S.1    Schwarcz, R.2
  • 104
    • 0034098766 scopus 로고    scopus 로고
    • Transport of glutamate and other amino acids at the blood-brain barrier
    • Smith QR. Transport of glutamate and other amino acids at the blood-brain barrier. J Nutr 2000; 130: 1016S-22S.
    • (2000) J Nutr , vol.130
    • Smith, Q.R.1
  • 105
    • 0034023008 scopus 로고    scopus 로고
    • Antiinflammatory drugs: A hope for Alzheimer's disease?
    • Hull M, Lieb K, Fiebich, BL. Antiinflammatory drugs: a hope for Alzheimer's disease? Expert Opin Invest Drugs 2000; 9: 671-83.
    • (2000) Expert Opin Invest Drugs , vol.9 , pp. 671-683
    • Hull, M.1    Lieb, K.2    Fiebich, B.L.3
  • 106
    • 0032970177 scopus 로고    scopus 로고
    • Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the nonsteroidal antiinflammatory drug,flufenamic acid
    • Baures PW, Oza V B, Peterson SA, Kelly JW. Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the nonsteroidal antiinflammatory drug,flufenamic acid. Bioorg Med Chem 1999, 7: 1339-47.
    • (1999) Bioorg Med Chem , vol.7 , pp. 1339-1347
    • Baures, P.W.1    Oza, V.B.2    Peterson, S.A.3    Kelly, J.W.4
  • 107
    • 0027319385 scopus 로고
    • Effect of ibuprofen on regional eicosanoid production and neuronal injury after forebrain ischemia in rats
    • Patel PM, Drummond JC, Sano T, Cole DJ, Kalkman CJ, Yaksh TL. Effect of ibuprofen on regional eicosanoid production and neuronal injury after forebrain ischemia in rats.Brain Res. 1993; 614: 315-24.
    • (1993) Brain Res , vol.614 , pp. 315-324
    • Patel, P.M.1    Drummond, J.C.2    Sano, T.3    Cole, D.J.4    Kalkman, C.J.5    Yaksh, T.L.6
  • 108
    • 0033551684 scopus 로고    scopus 로고
    • Specificity of ascorbate analogues for ascorbate transport. Synthesis and detection of [125I]6-deoxy-6-iodo-L-ascorbic acid and characterization of its ascorbate-specific transport properties
    • Rumsey SC, Welch RW, Garraffo H M, et al. Specificity of ascorbate analogues for ascorbate transport. Synthesis and detection of [125I]6-deoxy-6-iodo-L-ascorbic acid and characterization of its ascorbate-specific transport properties. J Biol Chem 1999; 274: 23215-22.
    • (1999) J Biol Chem , vol.274 , pp. 23215-23222
    • Rumsey, S.C.1    Welch, R.W.2    Garraffo, H.M.3
  • 109
    • 9144238106 scopus 로고    scopus 로고
    • Transporter-mediated effects of diclofenamic acid and its ascorbyl pro-drug in the in vivo neurotropic activity as ascorbyl nipecotic acid coniugate
    • Dalpiaz A, Pavan B, Scaglianti M, et al. Transporter-mediated effects of diclofenamic acid and its ascorbyl pro-drug in the in vivo neurotropic activity as ascorbyl nipecotic acid coniugate. J Pharm Sci 2004; 93: 78-84.
    • (2004) J Pharm Sci , vol.93 , pp. 78-84
    • Dalpiaz, A.1    Pavan, B.2    Scaglianti, M.3
  • 110
    • 13544276366 scopus 로고    scopus 로고
    • Vitamin C and 6-aminovitamin C conjugates of diclofenac: Synthesis and evaluation
    • Dalpiaz A, Pavan B, Scaglianti M, et al. Vitamin C and 6-aminovitamin C conjugates of diclofenac: synthesis and evaluation. Int J Pharm 2005; 291: 171-81.
    • (2005) Int J Pharm , vol.291 , pp. 171-181
    • Dalpiaz, A.1    Pavan, B.2    Scaglianti, M.3
  • 111
    • 72449129104 scopus 로고    scopus 로고
    • Targeting glioma cells in vitro with ascorbate-conjugated pharmaceutical nanocarriers
    • Salmaso S, Pappalardo JS, Sawant RR, et al. Targeting glioma cells in vitro with ascorbate-conjugated pharmaceutical nanocarriers. Bioconjugate Chem 2009; 20: 2348-55.
    • (2009) Bioconjugate Chem , vol.20 , pp. 2348-2355
    • Salmaso, S.1    Pappalardo, J.S.2    Sawant, R.R.3
  • 112
    • 0028229150 scopus 로고
    • Disruption of mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
    • Schinkel AH, Smit JJM, van Telligen O, et al. Disruption of mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994; 77: 491-502.
    • (1994) Cell , vol.77 , pp. 491-502
    • Schinkel, A.H.1    Smit, J.J.M.2    van Telligen, O.3
  • 113
    • 0033526176 scopus 로고    scopus 로고
    • P-Glycoprotein, a gatekeeper in the blood-brain barrier
    • Schinkel AH. P-Glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Delivery Rev 1999; 36: 179-94.
    • (1999) Adv Drug Delivery Rev , vol.36 , pp. 179-194
    • Schinkel, A.H.1
  • 114
    • 0028825399 scopus 로고
    • Absence of the mdr1a Pglycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin and cyclosporin A
    • Schinkel AH, Wagenaar E, van Deemter L, Mol CAAM, Borst P. Absence of the mdr1a Pglycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin and cyclosporin A. J Clin Invest 1995; 96: 1698-705.
    • (1995) J Clin Invest , vol.96 , pp. 1698-1705
    • Schinkel, A.H.1    Wagenaar, E.2    van Deemter, L.3    Mol, C.A.A.M.4    Borst, P.5
  • 115
    • 0031757312 scopus 로고    scopus 로고
    • BBB transport and P-glycoprotein functionality using mdr1a(-/-) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine-123
    • de Lange ECM, de Bock G, Schinkel AH, de Boer AG, Breimer DD. BBB transport and P-glycoprotein functionality using mdr1a(-/-) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine-123. Pharm Res 1998; 15: 1657-65.
    • (1998) Pharm Res , vol.15 , pp. 1657-1665
    • de Lange, E.C.M.1    de Bock, G.2    Schinkel, A.H.3    de Boer, A.G.4    Breimer, D.D.5
  • 116
    • 0032807119 scopus 로고    scopus 로고
    • Glycoprotein-dependent disposition kinetics of tacrolimus: Studies in mdr1a knockout mice
    • Yokogawa K, Takahashi M, Tamai I, et al. Glycoprotein-dependent disposition kinetics of tacrolimus: Studies in mdr1a knockout mice. Pharm Res 1999; 16: 1213-8.
    • (1999) Pharm Res , vol.16 , pp. 1213-1218
    • Yokogawa, K.1    Takahashi, M.2    Tamai, I.3
  • 117
    • 0037457802 scopus 로고    scopus 로고
    • Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: An overview
    • Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 2003; 55: 3-29.
    • (2003) Adv Drug Deliv Rev , vol.55 , pp. 3-29
    • Schinkel, A.H.1    Jonker, J.W.2
  • 118
    • 33645830172 scopus 로고
    • A surface glicoprotein modulating drug permeability in Chinese hamster ovary cell mutants
    • Juliano RL, Ling V. A surface glicoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976; 455: 152-62.
    • (1976) Biochim Biophys Acta , vol.455 , pp. 152-162
    • Juliano, R.L.1    Ling, V.2
  • 119
    • 0020605073 scopus 로고
    • Daunorubicin-resistant Chinese hamster ovary cell expressing multidrug resistance and a cell surface P-glicoprotein
    • Kartner R., Shales M, Riordan JR, Ling V. Daunorubicin-resistant Chinese hamster ovary cell expressing multidrug resistance and a cell surface P-glicoprotein. Cancer Res 1983; 43: 4413-9.
    • (1983) Cancer Res , vol.43 , pp. 4413-4419
    • Kartner, R.1    Shales, M.2    Riordan, J.R.3    Ling, V.4
  • 121
    • 0030823912 scopus 로고    scopus 로고
    • P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain
    • Beaulieu E, Demeule L, Ghiteseu L, Beliveau R. P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain. Biochem J 1997; 326: 539-44.
    • Biochem J 1997 , vol.326 , pp. 539-544
    • Beaulieu, E.1    Demeule, L.2    Ghiteseu, L.3    Beliveau, R.4
  • 122
    • 0033616684 scopus 로고    scopus 로고
    • Choroid plexus epithelia expression of MDR1 p glycoprotein and multidrug resistance- associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier
    • Rao VV, Dahlheimer JL, Bardgett ME, et al. Choroid plexus epithelia expression of MDR1 p glycoprotein and multidrug resistance- associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc Natl Acad Sci USA 1999; 96: 3900-5.
    • (1999) Proc Natl Acad Sci USA , vol.96 , pp. 3900-3905
    • Rao, V.V.1    Dahlheimer, J.L.2    Bardgett, M.E.3
  • 123
    • 0035992274 scopus 로고    scopus 로고
    • P-glycoprotein in acute myeloid leukaemia: Therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype
    • Pallis M, Turzanski J, Higashi Y, Russell N. P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype. Leuk Lymphoma 2002; 43: 1221-8.
    • (2002) Leuk Lymphoma , vol.43 , pp. 1221-1228
    • Pallis, M.1    Turzanski, J.2    Higashi, Y.3    Russell, N.4
  • 124
    • 10744221309 scopus 로고    scopus 로고
    • Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp1)
    • Gennuso F, Fernetti C, Tirolo C, et al. Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp1). Proc Natl Acad Sci USA 2004; 101: 2470-5.
    • (2004) Proc Natl Acad Sci USA , vol.101 , pp. 2470-2475
    • Gennuso, F.1    Fernetti, C.2    Tirolo, C.3
  • 125
    • 0027221177 scopus 로고
    • Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells
    • Callaghan R, Riordan JR. Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells. J. Biol chem. 1993; 268: 16059-64.
    • (1993) J. Biol Chem , vol.268 , pp. 16059-16064
    • Callaghan, R.1    Riordan, J.R.2
  • 126
    • 0033844780 scopus 로고    scopus 로고
    • Morphine antinociception is enhanced in mdr1a gene-deficent mice
    • Zong J, Pollack GM. Morphine antinociception is enhanced in mdr1a gene-deficent mice. Pharm Res 2000; 17: 749-53.
    • (2000) Pharm Res , vol.17 , pp. 749-753
    • Zong, J.1    Pollack, G.M.2
  • 127
    • 0033060742 scopus 로고    scopus 로고
    • Effects of a potent and specific P-glycoprotein inhibitor on the blood brain barrier distribution and antinociceptive effect of morphin in the rat
    • Letrent SP, Pollack GM, Brouver KR, Brouver KLR. Effects of a potent and specific P-glycoprotein inhibitor on the blood brain barrier distribution and antinociceptive effect of morphin in the rat. Drug Metab Disps 1999; 27: 827-34.
    • (1999) Drug Metab Disps , vol.27 , pp. 827-834
    • Letrent, S.P.1    Pollack, G.M.2    Brouver, K.R.3    Brouver, K.L.R.4
  • 128
    • 0034888307 scopus 로고    scopus 로고
    • Affinity for the P-glycoprotein efflux pump at the blood-brain barrier may explain the lack of CNS side-effects of modern antihistamines
    • Chishty M, Reichel A, Siva, J, Abbott N J, Begley D J. Affinity for the P-glycoprotein efflux pump at the blood-brain barrier may explain the lack of CNS side-effects of modern antihistamines. J Drug Targ 2001; 9: 233-88.
    • (2001) J Drug Targ , vol.9 , pp. 233-288
    • Chishty, M.1    Reichel, A.2    Siva, J.3    Abbott, N.J.4    Begley, D.J.5
  • 129
    • 0141507948 scopus 로고    scopus 로고
    • P-glycoprotein influences the brain concentrations of cetirizine (Zyrtec), a second generation non-sedating antihistamine
    • Polli JW, Baughman TM, Humphreys JE, et al. P-glycoprotein influences the brain concentrations of cetirizine (Zyrtec), a second generation non-sedating antihistamine. J Pharm Sci 2003; 92: 2082-9.
    • (2003) J Pharm Sci , vol.92 , pp. 2082-2089
    • Polli, J.W.1    Baughman, T.M.2    Humphreys, J.E.3
  • 130
    • 0018770443 scopus 로고
    • Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity
    • Laduron PM, Leysen JE. Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity. Biochem Pharmacol 1979; 28: 2161-5.
    • (1979) Biochem Pharmacol , vol.28 , pp. 2161-2165
    • Laduron, P.M.1    Leysen, J.E.2
  • 131
    • 0029892497 scopus 로고    scopus 로고
    • Pglycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs
    • Schinkel AH, Wagenaar E, Mol CA, van Deemter L. Pglycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 1996; 97: 2517-24.
    • (1996) J Clin Invest , vol.97 , pp. 2517-2524
    • Schinkel, A.H.1    Wagenaar, E.2    Mol, C.A.3    van Deemter, L.4
  • 132
    • 0036827812 scopus 로고    scopus 로고
    • In vitro stability and in vivo pharmacokinetic studies of a model opioid peptide, H-Tyr-D-Ala- Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs
    • Yang JZ, Chen W, Borchardt RT. In vitro stability and in vivo pharmacokinetic studies of a model opioid peptide, H-Tyr-D-Ala- Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs. J Pharmacol Exp Ther 2002; 303: 840-8.
    • (2002) J Pharmacol Exp Ther , vol.303 , pp. 840-848
    • Yang, J.Z.1    Chen, W.2    Borchardt, R.T.3
  • 133
    • 0036288132 scopus 로고    scopus 로고
    • A modified coumarinic acid-based cyclic prodrug of an opioid peptide: Its enzymatic and chemical stability and cell permeation characteristics
    • Ouyang H, Tang F, Siahaan TJ, Borchardt RT. A modified coumarinic acid-based cyclic prodrug of an opioid peptide: its enzymatic and chemical stability and cell permeation characteristics. Pharm Res 2002; 19: 794-801.
    • (2002) Pharm Res , vol.19 , pp. 794-801
    • Ouyang, H.1    Tang, F.2    Siahaan, T.J.3    Borchardt, R.T.4
  • 134
    • 0036827575 scopus 로고    scopus 로고
    • Evaluation of the permeation characteristics of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs across the blood-brain barrier using an in situ perfused rat brain model
    • Chen W, Yang JZ, Andersen R, Nielsen LH, Borchardt RT. Evaluation of the permeation characteristics of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs across the blood-brain barrier using an in situ perfused rat brain model. J Pharmacol Exp Ther 2002; 303: 849-57.
    • (2002) J Pharmacol Exp Ther , vol.303 , pp. 849-857
    • Chen, W.1    Yang, J.Z.2    Andersen, R.3    Nielsen, L.H.4    Borchardt, R.T.5
  • 135
    • 33144469997 scopus 로고    scopus 로고
    • Effects of amino acid chirality and the chemical linker on the celle permeation characteristics of cyclic prodrugs of opioid peptides
    • Liederer BM, Fuchs T, Vander Velde D, Siahaan TJ, Borchardt RT. Effects of amino acid chirality and the chemical linker on the celle permeation characteristics of cyclic prodrugs of opioid peptides. J Med Chem, 2006; 49: 1261-70.
    • (2006) J Med Chem , vol.49 , pp. 1261-1270
    • Liederer, B.M.1    Fuchs, T.2    Vander Velde, D.3    Siahaan, T.J.4    Borchardt, R.T.5
  • 136
    • 0242584997 scopus 로고    scopus 로고
    • Lipophilicities of baclofen ester prodrugs correlate with affinities to the ATP-dependent efflux pump P-glycoprotein: Relevance for their permeation across the blood-brain barrier?
    • Leisen C, Langguth P, Herbert B, Dressler C, Koggel A, Spahn- Langguth H. Lipophilicities of baclofen ester prodrugs correlate with affinities to the ATP-dependent efflux pump P-glycoprotein: relevance for their permeation across the blood-brain barrier? Pharm Res 2003; 20: 772-8.
    • (2003) Pharm Res , vol.20 , pp. 772-778
    • Leisen, C.1    Langguth, P.2    Herbert, B.3    Dressler, C.4    Koggel, A.5    Spahn-Langguth, H.6
  • 137
    • 0034674901 scopus 로고    scopus 로고
    • A family of drug transporters: The multidrug resistance-associated proteins
    • Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000; 92: 1295-302.
    • (2000) J Natl Cancer Inst , vol.92 , pp. 1295-1302
    • Borst, P.1    Evers, R.2    Kool, M.3    Wijnholds, J.4
  • 138
    • 4344632950 scopus 로고    scopus 로고
    • Mrp4 confers resistance to topotecan and protects the brain from chemotherapy
    • Leggas M, Adachi M, Scheffer GL, Sun D, Wielinga P, Du G, et al. Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol Cell Biol 2004; 24: 7612-21.
    • (2004) Mol Cell Biol , vol.24 , pp. 7612-7621
    • Leggas, M.1    Adachi, M.2    Scheffer, G.L.3    Sun, D.4    Wielinga, P.5    du, G.6
  • 139
    • 6344265573 scopus 로고    scopus 로고
    • Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain
    • Nies A, Jedlitschky G, König J, et al. Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience 2004; 129: 349-60.
    • (2004) Neuroscience , vol.129 , pp. 349-360
    • Nies, A.1    Jedlitschky, G.2    König, J.3
  • 140
    • 13044249156 scopus 로고    scopus 로고
    • A multidrug resistance transporter from human MCF-7 breast cancer cells
    • Doyle LA, Yang W, Abruzzo LV, et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 1998; 95: 15665-70.
    • (1998) Proc Natl Acad Sci USA , vol.95 , pp. 15665-15670
    • Doyle, L.A.1    Yang, W.2    Abruzzo, L.V.3
  • 141
    • 0037113346 scopus 로고    scopus 로고
    • Localisation of breast cancer resistance protein in microvessel endothelium of human brain
    • Cooray HC, Blackmore CG, Maskell L, Barrand MA. Localisation of breast cancer resistance protein in microvessel endothelium of human brain. Neuroreport 2002; 13: 2059-63.
    • (2002) Neuroreport , vol.13 , pp. 2059-2063
    • Cooray, H.C.1    Blackmore, C.G.2    Maskell, L.3    Barrand, M.A.4
  • 142
    • 2342644918 scopus 로고    scopus 로고
    • Expression, up-regulation, and transport activity of the multidrugresistance protein Abcg2 at the mouse blood-brain barrier
    • Cisternino S, Mercier C, Bourasset F, Roux F, Scherrmann JM. Expression, up-regulation, and transport activity of the multidrugresistance protein Abcg2 at the mouse blood-brain barrier. Cancer Res 2004; 64: 3296-301.
    • (2004) Cancer Res , vol.64 , pp. 3296-3301
    • Cisternino, S.1    Mercier, C.2    Bourasset, F.3    Roux, F.4    Scherrmann, J.M.5
  • 143
    • 56749151204 scopus 로고    scopus 로고
    • ABC transporters, cytochromes P450 and their main transcription factors: Expression at the human blood-brain barrier
    • Dauchy S, Dutheil F, Weaver R, et al. ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem 2008; 107: 1518-28.
    • (2008) J Neurochem , vol.107 , pp. 1518-1528
    • Dauchy, S.1    Dutheil, F.2    Weaver, R.3
  • 144
    • 0037178852 scopus 로고    scopus 로고
    • Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice
    • Sweet DH, Miller DS, Pritchard JB, Fujiwara Y, Beier DR, Nigam SK. Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice. J Biol Chem 2002; 277: 26934-43.
    • (2002) J Biol Chem , vol.277 , pp. 26934-26943
    • Sweet, D.H.1    Miller, D.S.2    Pritchard, J.B.3    Fujiwara, Y.4    Beier, D.R.5    Nigam, S.K.6
  • 146
    • 0037383621 scopus 로고    scopus 로고
    • Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells
    • Mori S, Takanaga H, Ohtsuki S, et al. Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells. J Cereb Blood Flow Metab 2003; 23: 432-40.
    • (2003) J Cereb Blood Flow Metab , vol.23 , pp. 432-440
    • Mori, S.1    Takanaga, H.2    Ohtsuki, S.3
  • 147
    • 59649111761 scopus 로고    scopus 로고
    • Limited brain distribution of [3R, 4R, 5 S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxyl ate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4)
    • Ose A, Ito M, Kusuhara H, et al. Limited brain distribution of [3R, 4R, 5 S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxyl ate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4). Drug Metab Dispos 2009; 37: 315-21.
    • (2009) Drug Metab Dispos , vol.37 , pp. 315-321
    • Ose, A.1    Ito, M.2    Kusuhara, H.3
  • 148
    • 0033932502 scopus 로고    scopus 로고
    • Organic aniontransporting polypeptides mediate transport of opioid peptides across blood-brain barrier
    • Gao B, Hagenbuch B, Kullak-Ublick GA, Benke D, Aguzzi A, Meier PJ. Organic aniontransporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J Pharmacol Exp Ther 2000; 294: 73-9.
    • (2000) J Pharmacol Exp Ther , vol.294 , pp. 73-79
    • Gao, B.1    Hagenbuch, B.2    Kullak-Ublick, G.A.3    Benke, D.4    Aguzzi, A.5    Meier, P.J.6
  • 149
    • 15744367808 scopus 로고    scopus 로고
    • Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): Implications for altered drug disposition and central nervous system drug entry
    • Lee W, Glaeser H, Smith LH, et al. Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry. J Biol Chem 2005; 280: 9610-7.
    • (2005) J Biol Chem , vol.280 , pp. 9610-9617
    • Lee, W.1    Glaeser, H.2    Smith, L.H.3
  • 150
    • 0037334615 scopus 로고    scopus 로고
    • In vitro study of the functional expression of organic anion transporting polypeptide 3 at rat choroid plexus epithelial cells and its involvement in the cerebrospinal fluid-to-blood transport of estrone-3-sulfate
    • Ohtsuki S, Takizawa T, Takanaga H, et al. In vitro study of the functional expression of organic anion transporting polypeptide 3 at rat choroid plexus epithelial cells and its involvement in the cerebrospinal fluid-to-blood transport of estrone-3-sulfate. Mol Pharmacol 2003; 63: 532-7.
    • (2003) Mol Pharmacol , vol.63 , pp. 532-537
    • Ohtsuki, S.1    Takizawa, T.2    Takanaga, H.3
  • 151
    • 3342999996 scopus 로고    scopus 로고
    • Localization of organic anion transporting polypeptide 3 (oatp3) in mouse brain parenchymal and capillary endothelial cells
    • Ohtsuki S, Takizawa T, Takanaga H, Hori S, Hosoya K, Terasaki T. Localization of organic anion transporting polypeptide 3 (oatp3) in mouse brain parenchymal and capillary endothelial cells. J Neurochem 2004; 90: 743-9.
    • (2004) J Neurochem , vol.90 , pp. 743-749
    • Ohtsuki, S.1    Takizawa, T.2    Takanaga, H.3    Hori, S.4    Hosoya, K.5    Terasaki, T.6
  • 152
    • 77953128479 scopus 로고    scopus 로고
    • Regulation and role of organic anion-transporting polypeptides (OATPs) in drug delivery at the choroid plexus
    • Zhang H, Song YN, Liu WG, Guo XL, Yu LG. Regulation and role of organic anion-transporting polypeptides (OATPs) in drug delivery at the choroid plexus. J Clin Neurosci 2010; 17: 679-84.
    • (2010) J Clin Neurosci , vol.17 , pp. 679-684
    • Zhang, H.1    Song, Y.N.2    Liu, W.G.3    Guo, X.L.4    Yu, L.G.5
  • 153
    • 70449529637 scopus 로고    scopus 로고
    • Approaches to transport therapeutic drugs across the blood-brain barrier to treatbrain diseases
    • Gabathuler R. Approaches to transport therapeutic drugs across the blood-brain barrier to treatbrain diseases. Neurobiol Diseases 2010; 37: 48-57.
    • (2010) Neurobiol Diseases , vol.37 , pp. 48-57
    • Gabathuler, R.1
  • 154
    • 0141444564 scopus 로고    scopus 로고
    • Breaching the blood-brain barrier
    • Filmore D. Breaching the blood-brain barrier. Modern Drug Discovery 2002; 5: 22-4.
    • (2002) Modern Drug Discovery , vol.5 , pp. 22-24
    • Filmore, D.1
  • 155
    • 47749105642 scopus 로고    scopus 로고
    • Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses
    • Pardridge WM. Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses. Bioconjug Chem 2008; 19: 1327-38.
    • (2008) Bioconjug Chem , vol.19 , pp. 1327-1338
    • Pardridge, W.M.1
  • 156
    • 33748452503 scopus 로고    scopus 로고
    • Molecular Trojan horses for blood-brain barrier drug delivery
    • Pardridge WM. Molecular Trojan horses for blood-brain barrier drug delivery. Curr Opin Pharmacol 2006; 6: 494-500.
    • (2006) Curr Opin Pharmacol , vol.6 , pp. 494-500
    • Pardridge, W.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.